Microscopic polyarteritis with renal and cerebral involvement

2000 ◽  
Vol 15 (1-2) ◽  
pp. 134-135 ◽  
Author(s):  
P. V. Deshpande ◽  
R. Gilbert ◽  
H. Alton ◽  
D. V. Milford
Keyword(s):  
Cerebral Involvement ◽  
Microscopic Polyarteritis

scholarly journals New Concepts in Treatment of Malaria with Malignant Tertian Cerebral Involvement

BMJ ◽  
1971 ◽  
Vol 1 (5751) ◽  
pp. 714-716 ◽  
Author(s):  
H. Smitskamp ◽  
F. H. Wolthuis
Keyword(s):  
New Concepts ◽  
Cerebral Involvement

Effects of endotoxin and dexamethasone on cerebral malaria in mice

Parasitology ◽  
1995 ◽  
Vol 111 (4) ◽  
pp. 443-454 ◽  
Author(s):  
A. L. Neill ◽  
N. H. Hunt
Keyword(s):  
Cerebral Malaria ◽  
Evans Blue ◽  
Plasmodium Berghei ◽  
Tumour Necrosis ◽  
Brain Parenchyma ◽  
Post Inoculation ◽  
Cba Mice ◽  
Cerebral Involvement ◽  
The Brain ◽  
Necrosis Factor

SUMMARYCBA/T6 and DBA/2J mice inoculated withPlasmodium bergheiANKA (PbA) develop cerebral involvement 6–8 days post-inoculation, from which the CBA mice almost invariably die and the DBA mice recover. Dexamethasone (DXM; 80 mg/kg) given to inoculated CBA mice twice, on day 3 and again within 48 h, reduced the cerebral symptoms and prevented death from cerebral malaria. Plasma tumour necrosis factor (TNF) levels, which increased at the time of the cerebral symptoms, were also reduced in these DXM-treated mice. Intravenously administered Evans Blue, a dye which binds to albumin, diffused extensively across the blood-brain barrier only during the period of cerebral symptoms, in proportion to the severity of the cerebral symptoms and the disease. In PbA-infected CBA mice, cerebral symptoms and the amount of Evans Blue diffusing into the brain tissue were both reduced by DXM treatment, but only if the steroid was given on day 3 and again within 48 h. Endotoxin injected intravascularly into PbA-infected DBA mice after day 5 resulted in an exaggeration of cerebral symptoms and death between days 6 and 9. Plasma TNF and the amount of Evans Blue in the brain parenchyma increased above normal levels in these mice. Endotoxin injections had only minor effects on the severity of the cerebral symptoms in PbA-infected CBA mice and did not cause the animals to die sooner.

scholarly journals Galactosidase Alpha p.A143T Variant Fabry Disease May Result in a Phenotype With Multifocal Microvascular Cerebral Involvement at a Young Age

2018 ◽  
Vol 9 ◽  
Author(s):  
Lothar Hauth ◽  
Jeroen Kerstens ◽  
Laetitia Yperzeele ◽  
François Eyskens ◽  
Paul M. Parizel ◽  
...  
Keyword(s):  
Fabry Disease ◽  
Young Age ◽  
Cerebral Involvement

Congenital muscular dystrophy in two siblings with cataracts and slight cerebral involvement

1994 ◽  
Vol 11 (2) ◽  
pp. 141
Author(s):  
Umbertina C. Reed ◽  
Suely K.N. Marie ◽  
Ana M.C.B. Tsanaclis ◽  
Mary S. Carvalho ◽  
Jayme Roizenblatt ◽  
...  
Keyword(s):  
Muscular Dystrophy ◽  
Congenital Muscular Dystrophy ◽  
Cerebral Involvement

scholarly journals Disseminated Mycobacterium bovis Infection in Red Foxes (Vulpes vulpes) with Cerebral Involvement Found in Portugal

2014 ◽  
Vol 14 (7) ◽  
pp. 531-533 ◽  
Author(s):  
Ana C. Matos ◽  
Luis Figueira ◽  
Maria H. Martins ◽  
Manuela Matos ◽  
Márcia Morais ◽  
...  
Keyword(s):  
Mycobacterium Bovis ◽  
Vulpes Vulpes ◽  
Red Foxes ◽  
Cerebral Involvement

scholarly journals AN AUTOPSY CASE OF MICROSCOPIC POLYARTERITIS NODOSA

1980 ◽  
Vol 69 (6) ◽  
pp. 738-744
Author(s):  
Hidemitsu MATSUURA ◽  
Takayoshi TANABE ◽  
Hiroyuki OHMORI ◽  
Tsuneo NANBA ◽  
Katsuhiko KIMOTO ◽  
...  
Keyword(s):  
Polyarteritis Nodosa ◽  
Autopsy Case ◽  
Microscopic Polyarteritis

scholarly journals Paroxysmal Amnesia Attacks due to Hashimoto’s Encephalopathy

2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
Pelin Nar Senol ◽  
Aylin Bican Demir ◽  
Ibrahim Bora ◽  
Mustafa Bakar
Keyword(s):  
Cognitive Impairment ◽  
Antiepileptic Drug ◽  
Rare Disease ◽  
Psychiatric Symptoms ◽  
Thyroid Antibodies ◽  
Immunomodulatory Agents ◽  
Clinical Appearance ◽  
Hashimoto’S Encephalopathy ◽  
Eeg Abnormalities ◽  
Cerebral Involvement

Hashimoto’s encephalopathy is a rare disease which is thought to be autoimmune and steroid responsive. The syndrome is characterized by cognitive impairment, encephalopathy, psychiatric symptoms, and seizures associated with increased level of anti-thyroid antibodies. The exact pathophysiology underlying cerebral involvement is still lesser known. Although symptoms suggest a nonlesional encephalopathy in most of the cases, sometimes the clinical appearance can be subtle and may not respond to immunosuppressants or immunomodulatory agents. Here we report a case who presented with drowsiness and amnestic complaints associated with paroxysmal electroencephalography (EEG) abnormalities which could be treated only with an antiepileptic drug.

Sign in / Sign up

Export Citation Format

Share Document